Full Prescribing Information

Full Prescribing Information

Important Safety Information

Healthcare Professionals Site

POWERFUL RESULTS WITH STRONTIUM89

Proof of powerful pain relief

Unfortunately, nearly half of people with bone mets live in pain. Strontium89 is here to help. In study after study, Strontium89 has been shown to provide significant bone pain relief.

79%

PAIN RELIEF

In its pivotal trial, up to 79% of study participants had
REDUCED PAIN with Strontium89.*

Freedom from bone pain is possible

2x

PAIN FREE at
3 MONTHS

Twice as many study participants treated with Strontium89 were
PAIN FREE at 3 months compared with placebo.†

*In a multi-center Canadian placebo-controlled trial of 126 participants who had persistent pain after receiving external radiation therapy, after adding a single injection of Strontium89, 71% (n=42) of participants had a reduction in pain and analgesic scores compared with 61% (n=44) of participants taking placebo at 1 month, 79% (n=38) of participants had a reduction in pain and analgesic scores compared with 57% (n=35) of participants taking placebo at 2 months, and 61% (n=33) of participants had a reduction in pain and analgesic scores compared with 56% (n=34) of participants taking placebo at 3 months.

†In the same study,  after adding a single injection of Strontium89, 14.3% of participants (6/42)  had a reduction in pain and analgesic scores to zero, compared with 6.8%  of participants (3/44) taking placebo at 1 month, 13.2% of participants (5/38) had a reduction in pain and analgesic scores to zero compared with 8.6% of participants (3/35) taking placebo at 2 months, and 15.2% of participants (5/33) had a reduction in pain score and analgesic score to zero compared with 5.9% of participants (2/34) taking placebo at 3 months.

Fewer new pain sites

59%

Strontium89

At 3 months, no new bone mets pain sites* were experienced in more participants receiving Strontium89.

Vs.

34%

Placebo

Although Strontium89 can be taken with other types of treatments, these study participants achieved results without any increase in other pain medications.

VIEW

Indication and important safety information

INDICATION

Strontium89 (Strontium Chloride Sr-89 Injection, USP) is used for the relief of bone pain in patients with bone metastases. You should only use Strontium89 if you have been diagnosed with metastatic bone cancer.

IMPORTANT SAFETY INFORMATION

  • Strontium89 may affect bone marrow and may cause white blood cell and platelet counts to be lower than normal. To monitor these effects, your doctor will perform regular blood tests before and after your injection, usually at least every other week until your levels have recovered. This may take up to 6 months. Your doctor will decide if it is safe for you to get a repeat injection, 90 days later, if needed. If you already have seriously decreased bone marrow function, your doctor may decide that you should not receive Strontium89.
  • Tell your doctor if you are pregnant or planning to become pregnant. Strontium89 may cause harm to your unborn baby and should not be used if you are pregnant or planning to become pregnant. You should not nurse your baby while using Strontium89.
  • You should not use Strontium89 if you do not have cancer in your bone.
  • You should not use Strontium89 if you are younger than 18 years old.
  • You may feel flushed (your skin may get red and warm) right after your injection.
  • Side effects in clinical studies:
    • One patient died from a blood infection caused by a severely low white blood cell count.
    • A small number of patients reported a mild and brief increase in bone pain within 36 to 72 hours after injection that was controlled with oral pain medication.
    • One patient had chills and fever 12 hours after injection but recovered.
These are not all of the side effects of Strontium89. If you have any questions or concerns about side effects, you should contact your doctor.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.FDA.gov/medwatch or call (800) FDA-1088.

Please see full Prescribing Information

TOP

Contact Us

If you have questions about Strontium89 or would like to report an adverse event,

©2021 Q BioMed Inc. All rights reserved. US-SR89WEB_0010 MAR2021

The information contained in this section is intended for US healthcare professionals only.

Proceed
Cancel